Data provided by Nasdaq. Minimum 15 minutes delayed.
May 23, 2017
NantHealth Names Ronald A. Louks as Chief Operating Officer
CULVER CITY, Calif.--(BUSINESS WIRE)--May 23, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced the appointment of Ronald A. Louks as its Chief Operating Officer. “Ron brings senior level leadership and excellent experience, gained at some of the most highly regarded and well recognized companies in the world, including Blackberry, HTC and Sony Ericsson,” said Patrick ...
May 10, 2017
NantHealth Appoints Dr. Sandeep Reddy as Chief Medical Officer
Company adds established oncology expert to leadership team CULVER CITY, Calif.--(BUSINESS WIRE)--May 10, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today the appointment of Sandeep (Bobby) Reddy, MD, as Chief Medical Officer. In his new position, Dr. Reddy will be responsible for overseeing education, outreach, clinical development programs, and clinical trials for GP...
May 10, 2017
NantHealth Reports 16% Increase in 2017 First Quarter Total Net Revenue; SaaS Revenue Rose 11% and GPS Adoption Continues to Climb
GPS Adoption: GPS Cancer Test to Be Complementary Diagnostic for FDA Authorized Nant Cancer Vaccine Clinical Trials, the First Novel Combination of Innate and Adaptive Immunotherapy in Patients with Pancreatic Cancer 365 GPS Commercial Tests Ordered in Q1, Up from 326 in Q4 ‘16 266 GPS Commercial Tests Delivered in Q1, Up from 233 in Q4 ‘16 ...